跳至主要内容
临床试验/CTRI/2026/02/103384
CTRI/2026/02/103384尚未招募不适用

To Study The Prevalence Of Polypharmacy Among Patients With Hypertension At Tertiary Care Centre

Aniruddha Sinha1 个研究点 分布在 1 个国家目标入组 241 人开始时间: 2026年3月5日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
241
试验地点
1

研究概览

简要总结

This study aims to assess the prevalence of polypharmacy among patients with hypertension attending a tertiary care center. Polypharmacy is defined as the concurrent use of five or more prescribed medications. Hypertension is a common chronic condition that often coexists with other diseases such as diabetes mellitus and cardiovascular disorders leading to the use of multiple drugs. The increasing burden of polypharmacy is associated with adverse drug reactions drug  drug interactions medication nonadherence and increased healthcare costs.

This is a prospective observational cross sectional study conducted in the Department of Pharmacology in collaboration with the Department of Medicine at a tertiary care hospital. Adult patients aged thirty years and above diagnosed with hypertension and attending the outpatient department during the study period will be included after obtaining informed consent. Demographic details clinical parameters comorbid conditions and complete medication profiles will be recorded using a structured proforma.

The primary outcome of the study is to determine the prevalence of polypharmacy among hypertensive patients. Secondary outcomes include assessment of appropriateness of polypharmacy evaluation of factors associated with polypharmacy analysis of antihypertensive prescribing patterns and identification of potential drug drug interactions and adverse drug reactions. Data will be analyzed using descriptive statistical methods. The findings of this study are expected to provide insight into prescribing practices and help promote rational use of medicines among hypertensive patients.

研究设计

研究类型
Observational

入排标准

年龄范围
30.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Adults of either gender.
  • Age should be more than 30 years and above.
  • Individuals having systolic blood pressure of 140-179mmHg and diastolic blood pressure of 90-109mmHg. Hypertensive patients.
  • Hypertensive patients with co morbid conditions such as diabetes mellitus etc.

排除标准

  • Patients who did not give informed consent.
  • Patients less than 18 years and more than 80 years old.
  • Patients with severe illness such as chronic kidney disease, malignancy.
  • Pregnant and lactating women.

研究者

发起方
Aniruddha Sinha
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr ANIL KUMAR

Baba Raghav Das Medical College Gorakhpur

研究点 (1)

Loading locations...

相似试验